Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Acer Therapeutics Inc (ACER)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Acer Therapeutics historical data, for real-time data please try another search
0.660 0.000    0.00%
20/11 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.660 - 0.850
Acer Therapeutics 0.660 0.000 0.00%

Acer Therapeutics Inc Company Profile

 
Get an in-depth profile of Acer Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

33

Equity Type

ORD

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. The company’s pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-801 for the treatment of induced Vasomotor Symptoms, post-traumatic stress disorder, and prostate cancer; and OLPRUVA, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease. It has a license agreement with Sanofi to acquire worldwide rights to Osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist; an option agreement with Relief for the development, regulatory approval, and commercialization of OLPRUVA; and an agreement with Emory University to acquire the worldwide intellectual property rights to a family of patents and patent applications related to the use of neurokinin receptor antagonists in managing conditioned fear and treating anxiety disorders, including post-traumatic stress disorder. The company was incorporated in 1991 and is headquartered in Newton, Massachusetts. As of August 31, 2023, Acer Therapeutics Inc. operates as a subsidiary of Zevra Therapeutics, Inc.

Contact Information

Address One Gateway Center Suite 356
300 Washington Street Newton, 02458
United States
Phone 844 902 6100
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ACER Comments

Write your thoughts about Acer Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JJ JJ
JJ JJ Dec 28, 2022 6:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fda approval and it tanks
Jack Belforte
Jack Belforte Dec 06, 2022 7:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Slow mover up the mountain. Shhhh.
jyotsna singhal
jyotsna singhal Dec 03, 2021 11:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is going on 😮😮😮
현태 정
현태 정 Oct 06, 2021 10:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats going on with this stock
jyotsna singhal
jyotsna singhal Jul 30, 2021 11:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats going on with this stock
Noel Jane
Noel Jane Jul 30, 2021 11:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
somethings not right with this stock
Raeid Alruwaili
Raeid Alruwaili Jul 29, 2021 2:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Friday big news 🙏🔥
Sanjeev Malhotra
Sanjeev Malhotra Jul 29, 2021 9:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seems good buy
Destiny Dawn
Destiny Dawn Mar 26, 2021 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is going on with this one
Hophop Recognize that
Dollarmachine Mar 15, 2021 10:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No sellers left, we can go to 10 dollar.
Geert Van Vaerenbergh
Gerardke Mar 15, 2021 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
see RLF otc
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email